Members |
acceptabilityId |
[X]Adverse reaction to blood substitutes: [macromolecular] or [plasma] (event) |
Preferred (foundation metadata concept) |
[X]Adverse reaction to caffeine |
Preferred (foundation metadata concept) |
[X]Adverse reaction to caffeine (disorder) |
Preferred (foundation metadata concept) |
[X]Adverse reaction to enzymes: [NOS] or [NEC] |
Preferred (foundation metadata concept) |
[X]Adverse reaction to enzymes: [NOS] or [NEC] (event) |
Preferred (foundation metadata concept) |
[X]Adverse reaction to lisinopril |
Acceptable (foundation metadata concept) |
[X]Adverse reaction to local anti-infective drug |
Acceptable (foundation metadata concept) |
[X]Adverse reaction to local anti-inflammatory drug |
Acceptable (foundation metadata concept) |
[X]Adverse reaction to local antifungal drug |
Acceptable (foundation metadata concept) |
[X]Adverse reaction to oral contraceptive: [therapeutic] or [unspecified] |
Preferred (foundation metadata concept) |
[X]Adverse reaction to oral contraceptive: [therapeutic] or [unspecified] (event) |
Preferred (foundation metadata concept) |
[X]Adverse reaction to other drug: [ENT] or [dental] or [NOS] or [unspecified topical agents] |
Preferred (foundation metadata concept) |
[X]Adverse reaction to other drug: [ENT] or [dental] or [NOS] or [unspecified topical agents] (event) |
Preferred (foundation metadata concept) |
[X]Adverse reaction to pneumococcal vaccine |
Acceptable (foundation metadata concept) |
[X]Affectionless psychopathy |
Acceptable (foundation metadata concept) |
[X]Affective psychosis NOS |
Acceptable (foundation metadata concept) |
[X]African trypanosomiasis, unspecified |
Preferred (foundation metadata concept) |
[X]African trypanosomiasis, unspecified (disorder) |
Preferred (foundation metadata concept) |
[X]Agents affecting calcification causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Agents affecting calcification causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Agents affecting uric acid metabolism causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Agents affecting uric acid metabolism causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Agents primarily acting on smooth and skeletal muscles and the respiratory system causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Agents primarily acting on smooth and skeletal muscles and the respiratory system causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting bone metabolism causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting bone metabolism causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting nutrition causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting nutrition causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting the gastrointestinal system causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting water-balance and mineral and uric acid metabolism causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Agents primarily affecting water-balance and mineral and uric acid metabolism causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Aggressive personality disorder |
Acceptable (foundation metadata concept) |
[X]Agoraphobia |
Acceptable (foundation metadata concept) |
[X]Agoraphobia without history of panic disorder |
Acceptable (foundation metadata concept) |
[X]Air and space transport accidents |
Preferred (foundation metadata concept) |
[X]Air and space transport accidents (event) |
Preferred (foundation metadata concept) |
[X]Airway disease due to other specific organic dusts |
Preferred (foundation metadata concept) |
[X]Airway disease due to other specific organic dusts (disorder) |
Preferred (foundation metadata concept) |
[X]Alcohol addiction |
Acceptable (foundation metadata concept) |
[X]Alcohol deterrents causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Alcohol deterrents causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Alcoholic dementia NOS |
Acceptable (foundation metadata concept) |
[X]Alcoholic hallucinosis |
Acceptable (foundation metadata concept) |
[X]Alcoholic jealousy |
Acceptable (foundation metadata concept) |
[X]Alcoholic paranoia |
Acceptable (foundation metadata concept) |
[X]Alcoholic psychosis NOS |
Acceptable (foundation metadata concept) |
[X]Allergic contact dermatitis due to other agents |
Preferred (foundation metadata concept) |
[X]Allergic contact dermatitis due to other agents (disorder) |
Preferred (foundation metadata concept) |
[X]Allergic contact dermatitis due to other chemical products |
Preferred (foundation metadata concept) |
[X]Allergic contact dermatitis due to other chemical products (disorder) |
Preferred (foundation metadata concept) |
[X]Alpha-adrenoreceptor antagonists causing adverse effects in therapeutic use, not elsewhere classified |
Preferred (foundation metadata concept) |
[X]Alpha-adrenoreceptor antagonists causing adverse effects in therapeutic use, not elsewhere classified (disorder) |
Preferred (foundation metadata concept) |
[X]Amebiasis, unspecified (disorder) |
Preferred (foundation metadata concept) |
[X]Amebic infection of other sites (disorder) |
Preferred (foundation metadata concept) |
[X]Aminoglycosides causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Aminoglycosides causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Amoebiasis, unspecified |
Preferred (foundation metadata concept) |
[X]Amoebic infection of other sites |
Preferred (foundation metadata concept) |
[X]Amputation of limb(s) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure |
Preferred (foundation metadata concept) |
[X]Amputation of limb(s) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure (disorder) |
Preferred (foundation metadata concept) |
[X]Anaemia (nonmegaloblastic) associated with other specified nutritional deficiencies |
Preferred (foundation metadata concept) |
[X]Anaemia in other chronic diseases classified elsewhere |
Preferred (foundation metadata concept) |
[X]Anaesthesiology devices associated with adverse incidents |
Preferred (foundation metadata concept) |
[X]Anaesthesiology devices associated with adverse incidents, diagnostic and monitoring devices |
Preferred (foundation metadata concept) |
[X]Anaesthesiology devices associated with adverse incidents, miscellaneous devices, not elsewhere classified |
Preferred (foundation metadata concept) |
[X]Anaesthesiology devices associated with adverse incidents, prosthetic and other implants, materials and accessory devices |
Preferred (foundation metadata concept) |
[X]Anaesthesiology devices associated with adverse incidents, surgical instruments, materials and devices (including sutures) |
Preferred (foundation metadata concept) |
[X]Anaesthesiology devices associated with adverse incidents, therapeutic (nonsurgical) and rehabilitative devices |
Preferred (foundation metadata concept) |
[X]Anaesthetics and therapeutic gases causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Analeptics causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Analeptics causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Analgesics, antipyretics and anti-inflammatory drugs causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Androgens and anabolic congeners causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Androgens and anabolic congeners causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Anemia (nonmegaloblastic) associated with other specified nutritional deficiencies (disorder) |
Preferred (foundation metadata concept) |
[X]Anemia in other chronic diseases classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Anesthesiology devices associated with adverse incidents (disorder) |
Preferred (foundation metadata concept) |
[X]Anesthesiology devices associated with adverse incidents, diagnostic and monitoring devices (disorder) |
Preferred (foundation metadata concept) |
[X]Anesthesiology devices associated with adverse incidents, miscellaneous devices, not elsewhere classified (disorder) |
Preferred (foundation metadata concept) |
[X]Anesthesiology devices associated with adverse incidents, prosthetic and other implants, materials and accessory devices (disorder) |
Preferred (foundation metadata concept) |
[X]Anesthesiology devices associated with adverse incidents, surgical instruments, materials and devices (including sutures) (disorder) |
Preferred (foundation metadata concept) |
[X]Anesthesiology devices associated with adverse incidents, therapeutic (nonsurgical) and rehabilitative devices (disorder) |
Preferred (foundation metadata concept) |
[X]Anesthetics and therapeutic gases causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Aneurysm of aorta in diseases classified elsewhere |
Preferred (foundation metadata concept) |
[X]Aneurysm of aorta in diseases classified elsewhere (disorder) |
Preferred (foundation metadata concept) |
[X]Aneurysm of other specified arteries |
Preferred (foundation metadata concept) |
[X]Aneurysm of other specified arteries (disorder) |
Preferred (foundation metadata concept) |
[X]Angiotensin II receptor antagonists causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Angiotensin II receptor antagonists causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Angiotensin-converting-enzyme inhibitors causing adverse effects in therapeutic use |
Preferred (foundation metadata concept) |
[X]Angiotensin-converting-enzyme inhibitors causing adverse effects in therapeutic use (disorder) |
Preferred (foundation metadata concept) |
[X]Animal phobias |
Acceptable (foundation metadata concept) |
[X]Animal-rider or occupant of animal-drawn vehicle injured in transport accident |
Preferred (foundation metadata concept) |
[X]Animal-rider or occupant of animal-drawn vehicle injured in transport accident (event) |
Preferred (foundation metadata concept) |
[X]Anogenital herpes viral infection, unspecified |
Preferred (foundation metadata concept) |